Table 3. Comparison of covariate balance before and after one to one matching across studies, with or without replacement, for each drug group, based upon standardized difference (%) of the logit of propensity score between groups.
Matching within studies | Matching across studies | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Exposure | Before matching | Matching without replacement | Matching with replacement | Matching without replacement | Matching with replacement | |||||
Std dif # (%) | p-value+ | Std dif (%) | p-value+ | Std dif (%) | p-value | Std dif (%) | p-value+ | Std dif (%) | p-value+ | |
Earlier generation FQN | -18.74 | <0.0001 | -23.58 | <0.001 | -2.90 | <0.001 | -14.61 | <0.001 | 0.05 | 0.022 |
Later generation FQN | -13.35 | <0.0001 | -26.53 | <0.001 | -17.44 | <0.001 | -12.79 | <0.001 | 0.13 | 0.14 |
Macrolide | -26.45 | <0.0001 | 12.48 | 0.06 | 9.01 | <0.001 | -6.37 | 0.118 | -0.03 | 0.542 |
# Std dif = Standardized difference of logit of propensity score in unexposed relative to exposed. FQN = fluoroquinolone.
+The differences in propensity score between exposed and unexposed individuals receiving were tested for significance using a paired t-test [34]